Regulations.gov document
Detailed IMS, Moving annual total (MAT) data indicating Approved Generic product…
Supporting & Related Material · FDA-2018-P-1869 · posted May 14, 2018
Key facts
| Document ID | FDA-2018-P-1869-0006 |
|---|---|
| Title | Detailed IMS, Moving annual total (MAT) data indicating Approved Generic product Dicyclomine Hydrochloride Capsules USP, 10 mg (ANDA # 085082), of Watson Laboratories Inc., as the leading player in the U.S market. re: Citizen Petition from Aurobindo Pharma USA Inc |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2018-P-1869 |
| Posted | May 14, 2018 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: